コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 the bromodomain-containing protein 4 and the positive transcription elongation factor b.
2 A stem-loop structure and recruitment of the positive transcription elongation factor b.
3 cyclin T2 (CCNT2), the regulatory subunit of positive transcription elongation factor b, a complex th
4 endent of its previously reported effects on positive transcription elongation factor b and HMBA indu
5 roductive transcriptional complex comprising positive transcription elongation factor b and RNA polym
6 ated kinase and the catalytic subunit of the positive-transcription elongation factor b and the Tat-a
7 Ser2P), together with CDK9, the component of positive transcription elongation factor b complex respo
8 on of additional BRD4 and associated P-TEFB (positive transcription elongation factor b) complexes in
9 ription elongation by recruiting the P-TEFb (positive transcription elongation factor-b) (CycT1:CDK9)
11 protein kinase heterodimer that constitutes positive transcription elongation factor b, is a well-va
12 the phosphorylation of RNA polymerase II by positive transcription elongation factor-b, leading to a
13 gely independent of the reduction of P-TEFb (positive transcription elongation factor b) levels cause
15 Here we present evidence that Tax recruits positive transcription elongation factor b (P-TEFb) (CDK
16 has identified a blockade in the specialized positive transcription elongation factor b (P-TEFb) acti
17 ex interplay between the recently discovered positive transcription elongation factor b (P-TEFb) and
18 ex interplay between the recently identified positive transcription elongation factor b (P-TEFb) and
19 s come from the recent identification of the positive transcription elongation factor b (P-TEFb) and
20 ith the bromodomain protein 4 (BRD4) and the positive transcription elongation factor b (P-TEFb) and
21 he human cyclin T1 (hCycT1) protein from the positive transcription elongation factor b (P-TEFb) bind
22 DG1/HEXIM1 was recently shown to inhibit the positive transcription elongation factor b (P-TEFb) by i
24 yclin T1, which together with CDK9 forms the positive transcription elongation factor b (P-TEFb) comp
25 t CDK9, which is the kinase component of the positive transcription elongation factor b (P-TEFb) comp
27 o as CLP-1), the inhibitory component of the positive transcription elongation factor b (P-TEFb) comp
28 interacting cyclin T partners belong to the positive transcription elongation factor b (P-TEFb) comp
32 tion of some genes has also been shown to be positive transcription elongation factor b (P-TEFb) depe
33 cal regulator of paused Pol II release, that positive transcription elongation factor b (P-TEFb) dire
35 r-bound DDX21 facilitates the release of the positive transcription elongation factor b (P-TEFb) from
36 n or on episomal plasmids also released free positive transcription elongation factor b (P-TEFb) from
39 y RNA polymerase II (Pol II) is regulated by positive transcription elongation factor b (P-TEFb) in a
40 trast, we do not find evidence for a role of positive transcription elongation factor b (P-TEFb) in t
41 HIV-1 Tat (transactivator of transcription)-positive transcription elongation factor b (P-TEFb) inte
42 ith initiation, in particular members of the positive transcription elongation factor b (P-TEFb) invo
47 C-terminal domain of RNA polymerase II, the positive transcription elongation factor b (P-TEFb) is t
49 omoter, although the level of binding of the positive transcription elongation factor b (P-TEFb) kina
50 ranscription elongation is stimulated by the positive transcription elongation factor b (P-TEFb) kina
51 haracterized as the catalytic subunit of the positive transcription elongation factor b (P-TEFb) of R
53 Regulation of transcription elongation by positive transcription elongation factor b (P-TEFb) play
56 , efficient and sustained HIV elongation and positive transcription elongation factor b (P-TEFb) recr
59 elongation is proposed to be controlled by a positive transcription elongation factor b (P-TEFb) thro
63 1 genes, the transactivator Tat recruits the positive transcription elongation factor b (P-TEFb) to t
64 al viral Tat protein requires recruitment of positive transcription elongation factor b (P-TEFb) to t
65 requires Tat-dependent recruitment of human positive transcription elongation factor b (P-TEFb) to t
66 f Tat and the cyclin T1 (CycT1) component of positive transcription elongation factor b (P-TEFb) to T
67 binding protein-associated factor (PCAF) and positive transcription elongation factor b (P-TEFb) to T
68 criptional transactivator (Tat) recruits the positive transcription elongation factor b (P-TEFb) to t
69 cy virus type 1 (HIV-1) Tat protein recruits positive transcription elongation factor b (P-TEFb) to t
70 observe that phospho-Ser(276) RelA binds the positive transcription elongation factor b (P-TEFb), a c
72 otein (snRNP) sequesters and inactivates the positive transcription elongation factor b (P-TEFb), an
73 uitylates AIRE, increases its binding to the positive transcription elongation factor b (P-TEFb), and
80 candidate general elongation factors are the positive transcription elongation factor b (P-TEFb), ele
83 A polymerase II kinase and elongation factor positive transcription elongation factor b (P-TEFb), the
84 strated that RBPJ binds CDK9, a component of positive transcription elongation factor b (P-TEFb), to
85 rminal domain of RNA polymerase II (RNAPII), positive transcription elongation factor b (P-TEFb), whi
86 1 (HEXIM1) is best known as the inhibitor of positive transcription elongation factor b (P-TEFb), whi
87 A polymerase II (RNAPII) is regulated by the positive transcription elongation factor b (P-TEFb), whi
88 the binding between a prototypic AAD and the positive transcription elongation factor b (P-TEFb), whi
89 A polymerase II (RNAPII) is regulated by the positive transcription elongation factor b (P-TEFb).
91 ir target is the human homolog of Drosophila positive transcription elongation factor b (P-TEFb).
92 cyclin-dependent kinases CDK13 and CDK11 and positive transcription elongation factor b (P-TEFb).
93 , in part, by the postinitiation activity of positive transcription elongation factor b (P-TEFb).
95 he histone H3-K79 methyltransferase DOT1 and positive transcription elongation factor b (P-TEFb).
96 ubunits of transcription factor (TF) IIH and positive transcription elongation factor b (P-TEFb).
97 se II complex is critically dependent on the positive transcription elongation factor b (P-TEFb).
98 RNA polymerase II elongation factor known as positive transcription elongation factor b (P-TEFb).
99 a functional interaction between ERalpha and positive transcription elongation factor b (P-TEFb).
100 milar to the animal CDK9-CycT complex of the positive transcription elongation factor b (P-TEFb).
101 that mediates its specific interaction with positive transcription elongation factor b (P-TEFb).
102 clear complexes, referred to collectively as positive transcription elongation factor b (P-TEFb).
103 with cyclinT1 and Cdk9 that constitutes core positive transcription elongation factor b (P-TEFb).
104 ic genes by RNA polymerase II depends on the positive transcription elongation factor b (P-TEFb).
105 erase II requires the kinase activity of the positive transcription elongation factor b (P-TEFb).
106 nd the binding of Tat to the cellular kinase positive transcription elongation factor b (P-TEFb).
107 f global transcription via the inhibition of positive transcription elongation factor b (P-TEFb).
108 in T1 structurally and functionally from the positive transcription elongation factor b (P-TEFb).
109 ransactivator Tat and its cellular cofactor, positive transcription elongation factor b (P-TEFb).
110 t transcription elongation by inhibiting the positive transcription elongation factor b (P-TEFb, a co
111 ptional suppressor through the inhibition of positive transcription elongation factor b (P-TEFb; CDK9
112 regulation and apoptosis was mimicked by the positive transcription elongation factor-b (P-TEFb) inhi
114 kinase 9 (CDK9), the catalytic component of positive transcription elongation factor-b, phosphorylat
115 F (DRB Sensitivity-Inducing Factor), P-TEFb (Positive Transcription Elongation Factor b), TFIIH, TFII
116 terminal domain and increased recruitment of positive transcription elongation factor b to the LTR pr
117 ones to regulate transcription by recruiting Positive Transcription Elongation Factor b to the promot
118 different strategies to recruit Tat and the positive transcription elongation factor b to their prom
119 cdks tested, cdk-9, the catalytic subunit of positive transcription elongation factor b, was signific
120 ase TAK and of the elongation factor P-TEFb (positive transcription elongation factor-b), which consi
121 ins BD1 and BD2 and forms a complex with the positive transcription elongation factor b, which contro
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。